Revista Colombiana de Endocrinología, Diabetes y Metabolismo
Asociación Colombiana de Endocrinología
Journal websitePeer review: Double-blind review
Evaluation status available after sign-in
About the journal
Revista Colombiana de Endocrinología, Diabetes y Metabolismo is an open-access journal published by Asociación Colombiana de Endocrinología in Colombia, publishing in english and spanish. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Asociación Colombiana de Endocrinología
- ISSN
- 2389-9786 · 2805-5853
- Country
- Colombia
- Languages
- english, spanish
- Access
- Open access
- Articles in DOAJ
- 795
- Declared review time
- 12 weeks
- Declared peer-review model
- double_blind
- Official website
- https://revistaendocrino.org/index.php/rcedm/index
Index listings
- DOAJ · 2023-02-24
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 12 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
795
Most recent article
last month
Average review time (journal-declared via DOAJ)
12weeks
Works in OpenAlex
574
Last recorded publication year
2025
Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
5
i10-index
0
From OpenAlex open data (CC0).
Editorial & policy10
- Last DOAJ review date
- 2023-02-24
- Added to DOAJ
- 2023-02-24
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- PKP PN
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 89%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity1
- Source type
- journal
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
LCC codes
RC648-665
Subject areas
- Health and Lifestyle Studies
- Health and Lifestyle Studies
- Thyroid Disorders and Treatments
- Diabetes Management and Research
- Thyroid and Parathyroid Surgery
- Thyroid Cancer Diagnosis and Treatment
- Diabetes Treatment and Management
- Adrenal Hormones and Disorders
Show all subjects (75)
- Pituitary Gland Disorders and Treatments
- Thyroid Disorders and Treatments
- Thyroid Disorders and Treatments
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Bone health and osteoporosis research
- History of Science and Medicine
- Diabetes Management and Education
- Parathyroid Disorders and Treatments
- Neuroendocrine Tumor Research Advances
- Pituitary Gland Disorders and Treatments
- Pituitary Gland Disorders and Treatments
- Medical History and Innovations
- Diabetes and associated disorders
- Diabetes and associated disorders
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Cancer Diagnosis and Treatment
- Diabetes Management and Research
- Diabetes Management and Research
- Vitamin D Research Studies
- Hormonal Regulation and Hypertension
- Hormonal Regulation and Hypertension
- Adrenal Hormones and Disorders
- Public Health and Environmental Issues
- Health and Medical Education
- Adrenal Hormones and Disorders
- Health and Medical Education
- Public Health and Environmental Issues
- Adrenal and Paraganglionic Tumors
- Growth Hormone and Insulin-like Growth Factors
- Adrenal and Paraganglionic Tumors
- Adrenal and Paraganglionic Tumors
- Medical research and treatments
- Medical research and treatments
- Ethics and bioethics in healthcare
- Ethics and bioethics in healthcare
- Diabetes and associated disorders
- COVID-19 Clinical Research Studies
- Vitamin D Research Studies
- Vitamin D Research Studies
- Bone Metabolism and Diseases
- Parathyroid Disorders and Treatments
- Obesity, Physical Activity, Diet
- Sexual Differentiation and Disorders
- Parathyroid Disorders and Treatments
- Aging, Health, and Disability
- Neuroendocrine Tumor Research Advances
- Aging, Health, and Disability
- Neuroendocrine Tumor Research Advances
- Neuroblastoma Research and Treatments
- Electrolyte and hormonal disorders
- Adipokines, Inflammation, and Metabolic Diseases
- Health, Education, and Physical Culture
- Sexual Differentiation and Disorders
- Sexual Differentiation and Disorders
- Health, Education, and Physical Culture
- Neuroblastoma Research and Treatments
- Pancreatic function and diabetes
- Nutrition and Health in Aging
- Nutrition and Health in Aging
- Growth Hormone and Insulin-like Growth Factors
- Diet and metabolism studies
- Growth Hormone and Insulin-like Growth Factors
- Diet and metabolism studies
- COVID-19 Clinical Research Studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes, Cardiovascular Risks, and Lipoproteins
- COVID-19 Clinical Research Studies
Keywords (DOAJ)
- endocrinology
- diabetes
- osteoporosis
- obesity and nutrition
- dyslipidemias
- molecular biology and endocrinology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ